Market revenue in 2023 | USD 8,588.4 million |
Market revenue in 2030 | USD 14,784.6 million |
Growth rate | 8.1% (CAGR from 2023 to 2030) |
Largest segment | Transdermal patches |
Fastest growing segment | Photodynamic Therapy Devices |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Photodynamic Therapy Devices, Transdermal Patches, Wound Care Products, Infusion Pumps, Orthopedic Combination Products, Drug Eluting Stents, Inhalers, Antimicrobial Catheters |
Key market players worldwide | Abbott Laboratories, Terumo Corp, Stryker Corp, Viatris Inc, Medtronic PLC, Boston Scientific Corp, Novartis AG ADR, Becton Dickinson & Co, Teleflex Inc, W L Gore & Associates |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug device combination products market will help companies and investors design strategic landscapes.
Transdermal patches was the largest segment with a revenue share of 23.14% in 2023. Horizon Databook has segmented the UK drug device combination products market based on photodynamic therapy devices, transdermal patches, wound care products, infusion pumps, orthopedic combination products, drug eluting stents, inhalers, antimicrobial catheters covering the revenue growth of each sub-segment from 2018 to 2030.
The UK drug device combination products market is anticipated to witness lucrative growth over the forecast period. High per capita income, the presence of an established healthcare system, a significant number of healthcare professionals, proper access to healthcare services, availability of advanced devices, and favorable reimbursement policies are among the major factors expected to drive the drug device combination products market in the UK.
Furthermore, the presence of well-trained & skilled surgeons, technological advancements, favorable government initiatives, rising healthcare expenditure, and high adoption of minimally invasive surgeries are expected to contribute to market growth. The presence of efficient reimbursement policies and the growing burden of chronic illness is expected to increase the number of scanning procedures.
Furthermore, the growing geriatric population, the rising prevalence of lifestyle diseases, and the presence of key players in the market are expected to propel market growth over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the UK drug device combination products market , including forecasts for subscribers. This country databook contains high-level insights into UK drug device combination products market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account